StockData
Lisata Therapeutics, Inc. logo

Lisata Therapeutics, Inc. (LSTA) stock

LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.98−0.06 (-5.76%)

Close on Nov 18, 2026Market cap $8.83MP/E –Yield –

Lisata Therapeutics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Lisata Therapeutics's free cash flow for the twelve months ending Jun 30, 2026 was -$12.32M. For fiscal 2025 it was -$15.98M. The highest annual figure on record is -$8.84M in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$15.98M–
FY2024Dec 31, 2024-$19.36M–
FY2023Dec 31, 2023-$20.03M–
FY2022Dec 31, 2022-$21.46M–
FY2021Dec 31, 2021-$22.31M–
FY2020Dec 31, 2020-$8.84M–
FY2019Dec 31, 2019-$18.88M–
FY2018Dec 31, 2018-$20.12M–
FY2017Dec 31, 2017-$21.01M–
FY2016Dec 31, 2016-$24.77M–
FY2015Dec 31, 2015-$42.44M–
FY2014Dec 31, 2014-$50.55M–
FY2013Dec 31, 2013-$29.79M–
FY2012Dec 31, 2012-$14.38M–
FY2011Dec 31, 2011-$21.50M–
FY2010Dec 31, 2010-$24.85M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.65M–
Q1 FY2026Mar 31, 2026-$3.08M–
Q4 FY2025Dec 31, 2025-$3.25M–
Q3 FY2025Sep 30, 2025-$3.34M–
Q2 FY2025Jun 30, 2025-$3.96M–
Q1 FY2025Mar 31, 2025-$5.43M–
Q4 FY2024Dec 31, 2024-$4.53M–
Q3 FY2024Sep 30, 2024-$2.52M–
Q2 FY2024Jun 30, 2024-$5.28M–
Q1 FY2024Mar 31, 2024-$7.03M–
Q4 FY2023Dec 31, 2023-$4.07M–
Q3 FY2023Sep 30, 2023-$3.58M–
Q4 FY2022Dec 31, 2022-$6.49M–
Q3 FY2022Sep 30, 2022-$4.02M–
Q4 FY2021Dec 31, 2021-$4.60M–
Q3 FY2021Sep 30, 2021-$5.04M–
Q2 FY2021Jun 30, 2021-$4.69M-204.4%
Q1 FY2021Mar 31, 2021-$7.98M–
Q4 FY2020Dec 31, 2020-$5.57M–
Q3 FY2020Sep 30, 2020-$3.52M–
Q2 FY2020Jun 30, 2020$4.49M–
Q1 FY2020Mar 31, 2020-$4.24M–
Q4 FY2019Dec 31, 2019-$4.22M–
Q3 FY2019Sep 30, 2019-$4.46M–
Q2 FY2019Jun 30, 2019-$4.72M–
Q1 FY2019Mar 31, 2019-$5.49M–
Q4 FY2018Dec 31, 2018-$3.04M–
Q3 FY2018Sep 30, 2018-$4.88M–
Q2 FY2018Jun 30, 2018-$5.89M–
Q1 FY2018Mar 31, 2018-$6.31M–
Q4 FY2017Dec 31, 2017-$3.99M–
Q3 FY2017Sep 30, 2017-$6.35M–
Q2 FY2017Jun 30, 2017-$515.89K–
Q1 FY2017Mar 31, 2017-$10.16M–
Q4 FY2016Dec 31, 2016-$3.41M–
Q3 FY2016Sep 30, 2016-$5.72M–

More Lisata Therapeutics figures

See a number that looks wrong?